cept Therapeutics rporated(CORT) - 2025 Q4 - Annual Results

EXHIBIT 99.1 Net income was $24.3 million in the fourth quarter, or $0.20 diluted net income per common share, compared to net income of $30.7 million, or $0.26 diluted net income per common share, in the fourth quarter of 2024. For the full year, net income was $99.7 million, or $0.82 diluted net income per common share, compared to net income of $141.2 million, or $1.23 diluted net income per common share, in 2024. Cash and investments were $532.4 million at December 31, 2025, compared to $603.2 million a ...